- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dietary Protein in Japan
Total 240 results
-
TakedaActive, not recruitingCongenital Protein C DeficiencyJapan
-
TakedaCompleted
-
TakedaCompleted
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
BayerActive, not recruiting
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Nara Medical UniversityShireUnknownHemophilia A With InhibitorJapan
-
Janssen Pharmaceutical K.K.Completed
-
CelgeneCompleted
-
Chiba UniversityCompleted
-
GlaxoSmithKlineActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Novo Nordisk A/SEnrolling by invitationHaemophilia A | Haemophilia BJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
Bristol-Myers SquibbCompleted
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
CelgeneCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AJapan
-
Kiminori Kimura, MDJapan Agency for Medical Research and Development; Ohara Pharmaceutical Co....Completed
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Bristol-Myers SquibbAbbVieNo longer available
-
BioMarin PharmaceuticalActive, not recruiting
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BSpain, Germany, Japan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
Kiminori Kimura, MDJapan Agency for Medical Research and DevelopmentRecruiting
-
CelgeneCompleted
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Celgene CorporationCompleted
-
Novartis PharmaceuticalsCompleted
-
Janssen Pharmaceutical K.K.CompletedWaldenstrom MacroglobulinemiaJapan